We are live on ! Find out more
JY

Jeff Yass Susquehanna International Group

AUM $1.28T
1-Year Est. Return 58.89%
 

Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.

This Fund
S&P 500
This Quarter Est. Return
-2.95%
1 Year Est. Return
+58.89%
3 Year Est. Return
+161.44%
5 Year Est. Return
+153.95%
10 Year Est. Return
+545.54%
AUM
$481B
AUM Growth
-$11.2B
Cap. Flow
+$6.33B
Cap. Flow %
1.32%
Top 10 Hldgs %
27.75%
Holding
13,532
New
1,585
Increased
5,250
Reduced
4,926
Closed
1,614

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$3.26B
2
QQQ icon
Invesco QQQ Trust
QQQ
+$2.12B
3
AAPL icon
Apple
AAPL
+$986M
4
AMZN icon
Amazon
AMZN
+$676M
5
KVUE icon
Kenvue
KVUE
+$501M

Sector Composition

Rank Sector Weight
1 Technology 2.36%
2 Consumer Discretionary 1.65%
3 Financials 1.08%
4 Healthcare 0.89%
5 Communication Services 0.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CATX icon
11726
Perspective Therapeutics
CATX
$376M
$5.29K ﹤0.01%
1,934
+287
+17% +$1.34K
BIOSW
11727
DELISTED
BioPlus Acquisition Corp. Warrants
BIOSW
$5.08K ﹤0.01%
+90,654
New +$10.8K
LIDR icon
11728
PUT
AEye
LIDR
$57.2M
$5.04K ﹤0.01%
+800
New +$6.42K
OCGN icon
11729
CALL
Ocugen
OCGN
$475M
$5K ﹤0.01%
12,500
-2,800
-18% -$1.38K
RDGT
11730
Ridgetech Inc
RDGT
$2.99M
$4.98K ﹤0.01%
7
-17
-71% -$16.9K
IRS.WS
11731
DELISTED
IRSA Inversiones y Representaciones S.A. Warrants
IRS.WS
$4.95K ﹤0.01%
+12,349
New +$5.69K
BCLI
11732
PUT
DELISTED
BRAINSTORM CELL THERAPUTC
BCLI
$4.92K ﹤0.01%
1,640
-27,747
-94% -$631K
VRAX icon
11733
Virax Biolabs
VRAX
$2.32M
$4.88K ﹤0.01%
+60
New +$5.62K
LANV.WS
11734
DELISTED
Lanvin Group Holdings Warrants
LANV.WS
$4.87K ﹤0.01%
+24,340
New +$5.61K
IBIO icon
11735
iBio
IBIO
$73M
$4.78K ﹤0.01%
+788
New +$6.81K
AIMAW
11736
DELISTED
Aimfinity Investment Corp I Warrant
AIMAW
$4.75K ﹤0.01%
101,599
+2,889
+3% +$142
QOMOR
11737
DELISTED
Qomolangma Acquisition Corp. Right
QOMOR
$4.7K ﹤0.01%
28,986
-1,000
-3% -$157
JAGX icon
11738
CALL
Jaguar Health
JAGX
$4.78M
0
NRXP icon
11739
CALL
NRX Pharmaceuticals
NRXP
$159M
$4.65K ﹤0.01%
1,790
-20
-1% -$67
TCRT icon
11740
CALL
Alaunos Therapeutics
TCRT
$4.55M
$4.65K ﹤0.01%
239
-23
-9% -$991
KULR icon
11741
CALL
KULR Technology Group
KULR
$126M
$4.64K ﹤0.01%
1,613
-1,550
-49% -$8.82K
ESLAW icon
11742
Estrella Immunopharma Warrant
ESLAW
$172K
$4.58K ﹤0.01%
19,064
-59,317
-76% -$9.82K
PPHPR
11743
DELISTED
PHP Ventures Acquisition Corp. Rights
PPHPR
$4.5K ﹤0.01%
29,997
-15,438
-34% -$2.49K
FLNT
11744
PUT
Fluent
FLNT
$126M
$4.4K ﹤0.01%
+1,667
New +$6.24K
KRRO icon
11745
Korro Bio
KRRO
$202M
$4.39K ﹤0.01%
240
FREEW
11746
DELISTED
Whole Earth Brands, Inc. Warrant
FREEW
$4.19K ﹤0.01%
+34,886
New +$5.37K
OPGN
11747
DELISTED
OpGen, Inc
OPGN
$4.08K ﹤0.01%
+1,019
New +$4.21K
GROY.WS
11748
DELISTED
Gold Royalty Corp. Warrants, each warrant exercisable for one common share at an exercise price of $7.50
GROY.WS
$4.02K ﹤0.01%
53,543
+7,209
+16% +$839
BXRX
11749
DELISTED
Baudax Bio, Inc. Common Stock
BXRX
$3.96K ﹤0.01%
+10,699
New +$6.11K
BODI icon
11750
CALL
The Beachbody Company
BODI
$44.8M
$3.81K ﹤0.01%
254

Similar funds

Jeff Yass's Q3 2023 Portfolio in Review

As of Q3 2023, Jeff Yass held 13,532 positions worth $481B, down 2.3% from $492B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Jeff Yass's Q3 2023 filing shows 1,585 new, 5,250 increased, 4,926 reduced and 1,614 closed positions. Its largest new stake was iShares JPMorgan USD Emerging Markets Bond ETF: 632,356 shares worth $52.2M. The largest sale was NVIDIA, an estimated $1.26B.

By sector, the portfolio is most concentrated in Technology at 2.4% of assets, down from 2.7% a quarter earlier, followed by Consumer Discretionary and Financials.

  • Jeff Yass's largest Q3 2023 buy was iShares JPMorgan USD Emerging Markets Bond ETF: 632,356 shares worth $52.2M.
  • Jeff Yass added most to State Street SPDR S&P 500 ETF Trust in Q3 2023, an estimated $3.26B increase.
  • Jeff Yass's biggest Q3 2023 reduction was NVIDIA, cutting an estimated $1.26B.
  • Jeff Yass fully exited Magellan Midstream Partners, L.P. in Q3 2023, selling an estimated $45.6M.
  • Jeff Yass's ten largest holdings make up 28% of its $481B portfolio in Q3 2023.
  • Jeff Yass opened 1,585 new positions and closed 1,614 in Q3 2023.
  • Jeff Yass's portfolio value fell 2.3% quarter-over-quarter to $481B.

Based on Susquehanna International Group's 13F filing for Q3 2023, filed 14 Nov 2023.